Group | Mean (SD) | Effect Size | p* | |
---|---|---|---|---|
BILAG General group | ||||
Baseline | C/D/E (n = 149) | 21.9 (12.0) | C/D/E vs B: 0.52 | < 0.001 |
B (n = 80) | 15.8 (9.7) | B vs A: 0.24 | ||
A (n = 25) | 13.1 (9.0) | |||
Week 12 | C/D/E (n = 201) | 25.9 (13.0) | 0.65 | 0.001 |
A/B (n = 29) | 17.5 (10.3) | |||
BILAG Musculoskeletal group | ||||
Baseline | C/D/E (n = 46) | 25.1 (13.4) | C/D/E vs B: 0.53 | < 0.001 |
B (n = 138) | 18.9 (11.1) | B vs A: 0.30 | ||
A (n = 70) | 15.7 (9.7) | |||
Week 12 | C/D/E (n = 157) | 26.8 (13.2) | C/D/E vs B: 0.42 | 0.003 |
B (n = 53) | 21.4 (11.5) | B vs A: 0.22 | ||
A (n = 20) | 18.8 (12.5) |
↵* ANOVA p value. FACIT: Functional Assessment of Chronic Illness Therapy; BILAG: British Isles Lupus Assessment Group.